Therapy News and Research

RSS

Edoxaban-based dual therapy noninferior to standard treatment in atrial fibrillation post-stenting

Edoxaban in combination with a P2Y12 inhibitor is noninferior to standard triple therapy for preventing bleeding in patients with atrial fibrillation after coronary stenting.

4 Sep 2019

Testosterone-containing nasal spray offers promising alternative for people suffering from 'low T'

A newly patented, testosterone-containing nasal spray developed by a psychology professor at The University of Texas at Austin could provide those suffering from testosterone deficiency and other ailments, such as anxiety disorders, with easily modulated, fast-acting results.

4 Sep 2019

Melatonin promises to help reduce bone loss in space flight

New research suggests that the problem of bone loss caused by microgravity conditions in space flight may be successfully treated using the time-tested drug melatonin. Melatonin increases the level of calcitonin in bone, which suppresses the bone-destroying activity of osteoclastic cells and helps maintain bone density.

4 Sep 2019

Breast cancer gene could be key to developing targeted therapy for hepatoblastoma

Hepatoblastoma is a rare form of liver cancer affecting just a few individuals per million. However, it is the leading cause of liver cancer in infants and young children, with most patients diagnosed before their third birthday.

4 Sep 2019

Study links FAK protein to chemotherapy resistance in ovarian cancer

Although the number of women being diagnosed and dying of ovarian cancer is declining, recurrence, drug resistance and mortality remain high for women with high-grade serous ovarian carcinoma, the most common form of epithelial ovarian cancer.

3 Sep 2019

UA receives $1.4 million grant for a peer-support program to help sleep apnea patients

University of Arizona College of Medicine - Tucson Professor Sairam Parthasarathy, MD, has been awarded nearly $1.4 million for a peer-support program for sleep apnea patients.

3 Sep 2019

CRISPR-Cas9 successfully reverses type 2 diabetes in mice

Researchers have used CRISPR-Cas9 to treat obesity and type 2 diabetes in mice, a development that could eventually benefit humans.

3 Sep 2019

ICD use associated with reduced mortality in patients with heart failure

Implantable cardioverter-defibrillator use is associated with reduced short- and long-term mortality in patients with heart failure, according to late-breaking research presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology and published in Circulation.

3 Sep 2019

Ticagrelor reduces heart attacks and strokes for patients with diabetes

In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women's Hospital and Greater Paris University Hospitals - AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study, a clinical trial sponsored by AstraZeneca that evaluated whether adding ticagrelor to aspirin improves outcomes for patients with stable coronary artery disease and diabetes mellitus but without a history of heart attack or stroke.

3 Sep 2019

Reducing secondary mitral regurgitation in heart failure does not lower death, hospitalization at two years

Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not lower death and hospitalization at two years compared to standard medical care, according to late breaking results from the MITRA-FR study presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology and simultaneously published in the European Journal of Heart Failure.

3 Sep 2019

Breast cancer cells can go into sleep mode and relapse in the future

Breast cancer is one of the most aggressive types of cancers in the world. It is the commonest cause of cancer death in women worldwide, and it represented about 12 percent of all new cancer cases in 2012. Current predictions and statistics suggest that both worldwide incidence of breast cancer and related mortality are on the rise. Globally, breast cancer now represents one in four of all cancers in women.

3 Sep 2019

Beta-blockers reduce mortality in patients with heart failure and moderate kidney dysfunction

Beta-blockers remain effective for preventing death in heart failure with reduced ejection fraction (HFrEF) and sinus rhythm, even in patients with moderate or moderately-severe kidney dysfunction, according to late breaking research presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology.

3 Sep 2019

Studies reveal how popular drug helps in heart failure

Results were released today from the first two clinical studies designed specifically to examine the effects of the heart drug sacubitril/valsartan on the structure and function of the failing heart.

3 Sep 2019

Community-based salt substitution program cuts new cases of hypertension

A community-based salt substitution program in Peru lowered blood pressure and cut new cases of hypertension. The late breaking research is presented in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology.

3 Sep 2019

New guidelines for management of a fast heartbeat released

At the ESC Congress 2019 held in Paris last weekend, the European Society of Cardiology (ESC) Guidelines on supraventricular tachycardia were published. The document titled, “2019 ESC Guidelines for the management of patients with supraventricular tachycardia.

2 Sep 2019

Therapy News and Research

Edoxaban-based dual therapy noninferior to standard treatment in atrial fibrillation post-stenting

Testosterone-containing nasal spray offers promising alternative for people suffering from 'low T'

Melatonin promises to help reduce bone loss in space flight

Breast cancer gene could be key to developing targeted therapy for hepatoblastoma

Study links FAK protein to chemotherapy resistance in ovarian cancer

UA receives $1.4 million grant for a peer-support program to help sleep apnea patients

CRISPR-Cas9 successfully reverses type 2 diabetes in mice

ICD use associated with reduced mortality in patients with heart failure

Ticagrelor reduces heart attacks and strokes for patients with diabetes

Reducing secondary mitral regurgitation in heart failure does not lower death, hospitalization at two years

Breast cancer cells can go into sleep mode and relapse in the future

Beta-blockers reduce mortality in patients with heart failure and moderate kidney dysfunction

Studies reveal how popular drug helps in heart failure

Community-based salt substitution program cuts new cases of hypertension

New guidelines for management of a fast heartbeat released

ARNI therapy trial misses target in heart failure, may have selective benefit only

Breakthrough study shows transplanting Hepatitis C-infected kidneys is safe

LDL cholesterol levels should be lowered as much as possible to prevent cardiovascular risk

ESC guidelines highlight detrimental impact of pollution, noise on patients with chronic coronary syndromes

New ESC guidelines for diagnosis and management of pulmonary embolism published

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News